Tissue genotyping of 37 in situ and invasive cervical cancer with a concomitant negative HC2 HPV DNA Test

Sarah Igidbashian, Maria Teresa Schettino, Sara Boveri, Massimo Barberis, Maria Teresa Sandri, Silvestro Carinelli, Maria Cannone, Mario Sideri

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVE: The rare occurrence of histology-proven cervical intraepithelial neoplasia grade 3 (CIN 3) or invasive cancer with a negative HC2 result is known. Tissue blocks of 37 cases of histology-diagnosed CIN 3+ with a concomitant negative HC2 test were genotyped to investigate the human papillomavirus (HPV) status within the lesion. METHODS: We considered 1,976 cervical excision specimens performed with concomitant HC2 test. Of these, 37 histology-confirmed CIN 3+ resulted HC2 negative. Thirty-three paraffin blocks, derived by the cervical excision, could be genotyped for high- (HR) and low-risk (LR) HPV genotypes. RESULTS: Detailed histology showed 30 CIN 3, 2 squamous cell invasive carcinomas, and 5 invasive adenocarcinomas. One specimen resulted not amplifiable at the genotyping. Twenty-two cases (68.7%) were positive for HR-HPV types, either in single (n = 17) or multiple HR-HPV infection (n = 5). Most of the HR-HPVs found were 16 or 18. Ten cases (31.3%) were negative for HR-HPV types; 5 of these were positive for probable HR-HPV types, not detectable with HC2 HR-probes, 1 was positive to LR-HPV types, while 1 had HPV-69/71. Three cases were negative for HPV DNA, either high or low risk. CONCLUSIONS: Of the rare cases of CIN 3+ lesions with concomitant negative HC2 test, 69% are true failures in HR-HPV detection. One third of HC2-negative CIN 3+ is related to the presence of other HPV genotypes not covered by the HC2 panel or to undetectable HPV in the lesion; both these rare occurrences were already described in large cancer series and partially explain the occurrence of HPV-negative CIN 3+.

Original languageEnglish
Pages (from-to)87-91
Number of pages5
JournalJournal of Lower Genital Tract Disease
Volume18
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Human Papillomavirus DNA Tests
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
Histology
Genotype
Papillomavirus Infections

Keywords

  • cervical cancer
  • CIN 3
  • high-risk HPV
  • HPV-negative CIN 3+

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Tissue genotyping of 37 in situ and invasive cervical cancer with a concomitant negative HC2 HPV DNA Test. / Igidbashian, Sarah; Schettino, Maria Teresa; Boveri, Sara; Barberis, Massimo; Sandri, Maria Teresa; Carinelli, Silvestro; Cannone, Maria; Sideri, Mario.

In: Journal of Lower Genital Tract Disease, Vol. 18, No. 1, 01.2014, p. 87-91.

Research output: Contribution to journalArticle

@article{8528c2c6b09b4e75aa884d9b86399e07,
title = "Tissue genotyping of 37 in situ and invasive cervical cancer with a concomitant negative HC2 HPV DNA Test",
abstract = "OBJECTIVE: The rare occurrence of histology-proven cervical intraepithelial neoplasia grade 3 (CIN 3) or invasive cancer with a negative HC2 result is known. Tissue blocks of 37 cases of histology-diagnosed CIN 3+ with a concomitant negative HC2 test were genotyped to investigate the human papillomavirus (HPV) status within the lesion. METHODS: We considered 1,976 cervical excision specimens performed with concomitant HC2 test. Of these, 37 histology-confirmed CIN 3+ resulted HC2 negative. Thirty-three paraffin blocks, derived by the cervical excision, could be genotyped for high- (HR) and low-risk (LR) HPV genotypes. RESULTS: Detailed histology showed 30 CIN 3, 2 squamous cell invasive carcinomas, and 5 invasive adenocarcinomas. One specimen resulted not amplifiable at the genotyping. Twenty-two cases (68.7{\%}) were positive for HR-HPV types, either in single (n = 17) or multiple HR-HPV infection (n = 5). Most of the HR-HPVs found were 16 or 18. Ten cases (31.3{\%}) were negative for HR-HPV types; 5 of these were positive for probable HR-HPV types, not detectable with HC2 HR-probes, 1 was positive to LR-HPV types, while 1 had HPV-69/71. Three cases were negative for HPV DNA, either high or low risk. CONCLUSIONS: Of the rare cases of CIN 3+ lesions with concomitant negative HC2 test, 69{\%} are true failures in HR-HPV detection. One third of HC2-negative CIN 3+ is related to the presence of other HPV genotypes not covered by the HC2 panel or to undetectable HPV in the lesion; both these rare occurrences were already described in large cancer series and partially explain the occurrence of HPV-negative CIN 3+.",
keywords = "cervical cancer, CIN 3, high-risk HPV, HPV-negative CIN 3+",
author = "Sarah Igidbashian and Schettino, {Maria Teresa} and Sara Boveri and Massimo Barberis and Sandri, {Maria Teresa} and Silvestro Carinelli and Maria Cannone and Mario Sideri",
year = "2014",
month = "1",
doi = "10.1097/LGT.0b013e3182909f86",
language = "English",
volume = "18",
pages = "87--91",
journal = "Journal of Lower Genital Tract Disease",
issn = "1089-2591",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Tissue genotyping of 37 in situ and invasive cervical cancer with a concomitant negative HC2 HPV DNA Test

AU - Igidbashian, Sarah

AU - Schettino, Maria Teresa

AU - Boveri, Sara

AU - Barberis, Massimo

AU - Sandri, Maria Teresa

AU - Carinelli, Silvestro

AU - Cannone, Maria

AU - Sideri, Mario

PY - 2014/1

Y1 - 2014/1

N2 - OBJECTIVE: The rare occurrence of histology-proven cervical intraepithelial neoplasia grade 3 (CIN 3) or invasive cancer with a negative HC2 result is known. Tissue blocks of 37 cases of histology-diagnosed CIN 3+ with a concomitant negative HC2 test were genotyped to investigate the human papillomavirus (HPV) status within the lesion. METHODS: We considered 1,976 cervical excision specimens performed with concomitant HC2 test. Of these, 37 histology-confirmed CIN 3+ resulted HC2 negative. Thirty-three paraffin blocks, derived by the cervical excision, could be genotyped for high- (HR) and low-risk (LR) HPV genotypes. RESULTS: Detailed histology showed 30 CIN 3, 2 squamous cell invasive carcinomas, and 5 invasive adenocarcinomas. One specimen resulted not amplifiable at the genotyping. Twenty-two cases (68.7%) were positive for HR-HPV types, either in single (n = 17) or multiple HR-HPV infection (n = 5). Most of the HR-HPVs found were 16 or 18. Ten cases (31.3%) were negative for HR-HPV types; 5 of these were positive for probable HR-HPV types, not detectable with HC2 HR-probes, 1 was positive to LR-HPV types, while 1 had HPV-69/71. Three cases were negative for HPV DNA, either high or low risk. CONCLUSIONS: Of the rare cases of CIN 3+ lesions with concomitant negative HC2 test, 69% are true failures in HR-HPV detection. One third of HC2-negative CIN 3+ is related to the presence of other HPV genotypes not covered by the HC2 panel or to undetectable HPV in the lesion; both these rare occurrences were already described in large cancer series and partially explain the occurrence of HPV-negative CIN 3+.

AB - OBJECTIVE: The rare occurrence of histology-proven cervical intraepithelial neoplasia grade 3 (CIN 3) or invasive cancer with a negative HC2 result is known. Tissue blocks of 37 cases of histology-diagnosed CIN 3+ with a concomitant negative HC2 test were genotyped to investigate the human papillomavirus (HPV) status within the lesion. METHODS: We considered 1,976 cervical excision specimens performed with concomitant HC2 test. Of these, 37 histology-confirmed CIN 3+ resulted HC2 negative. Thirty-three paraffin blocks, derived by the cervical excision, could be genotyped for high- (HR) and low-risk (LR) HPV genotypes. RESULTS: Detailed histology showed 30 CIN 3, 2 squamous cell invasive carcinomas, and 5 invasive adenocarcinomas. One specimen resulted not amplifiable at the genotyping. Twenty-two cases (68.7%) were positive for HR-HPV types, either in single (n = 17) or multiple HR-HPV infection (n = 5). Most of the HR-HPVs found were 16 or 18. Ten cases (31.3%) were negative for HR-HPV types; 5 of these were positive for probable HR-HPV types, not detectable with HC2 HR-probes, 1 was positive to LR-HPV types, while 1 had HPV-69/71. Three cases were negative for HPV DNA, either high or low risk. CONCLUSIONS: Of the rare cases of CIN 3+ lesions with concomitant negative HC2 test, 69% are true failures in HR-HPV detection. One third of HC2-negative CIN 3+ is related to the presence of other HPV genotypes not covered by the HC2 panel or to undetectable HPV in the lesion; both these rare occurrences were already described in large cancer series and partially explain the occurrence of HPV-negative CIN 3+.

KW - cervical cancer

KW - CIN 3

KW - high-risk HPV

KW - HPV-negative CIN 3+

UR - http://www.scopus.com/inward/record.url?scp=84894102488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894102488&partnerID=8YFLogxK

U2 - 10.1097/LGT.0b013e3182909f86

DO - 10.1097/LGT.0b013e3182909f86

M3 - Article

C2 - 23959298

AN - SCOPUS:84894102488

VL - 18

SP - 87

EP - 91

JO - Journal of Lower Genital Tract Disease

JF - Journal of Lower Genital Tract Disease

SN - 1089-2591

IS - 1

ER -